We got off to a solid and profitable start in 2013 with all four divisions contributing to our organic sales growth. In addition, we are making excellent progress on our ‘Fit for 2018’ program. This can clearly be seen in the 19% increase in EBITDA pre one-time items,” said Karl-Ludwig Kley, Chairman of the Executive Board

• A detailed presentation of the financial report 1st quarter 2013
• PDF download
• More information

We are one of the world's leading companies in innovative pharmaceuticals, life science tools and cutting-edge performance materials and technologies. Based on a tradition of nearly 125 years, we are driving value-adding technologies to benefit our patients and customers. We are guided by our corporate values of responsibility, respect, integrity, transparency, courage and achievement.

• Our Group
• Corporate Responsibility
• Working in our company

We offer our customers in the USA and Canada a wide range of products - from innovative prescription medicines to life science tools, industrial pigments and chemicals. For information on products and services, please contact us or visit the websites of our business divisions.

• Prescription medicines
• PERFORMANCE MATERIALS - High-tech chemicals
• Life science tools

Our employees contribute in interdisciplinary teams to fighting disease worldwide. In challenging research projects in our global R&D hubs.

• Read more about extraordinary perspectives
• Working in the Merck KGaA Group